Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Block Listing Application

12th Dec 2024 07:00

RNS Number : 7573P
Dr. Martens PLC
12 December 2024
 

12 December 2024

 

Dr. Martens plc (the "Company")

Block Listing application

 

The Company announces today that application has been made to the FCA and to the London Stock Exchange for admission to (i) the Official List and (ii) trading on the London Stock Exchange's main market for a block listing of securities in respect of a total of 15,000,000 ordinary shares of GBP 0.01 each (the "Ordinary Shares") in the Company. It is expected that admission will become effective on 16 December 2024.

The Ordinary Shares are being reserved under a block listing and will be issued as and when required under the Company's employee share plans.

When issued the Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.

 

Enquiries:

Investors and analysts

Bethany Barnes, Director of Investor Relations

[email protected]

 

Gill Hammond, Communications Director

[email protected]

 

Paul Rolling, Assistant Company Secretary

[email protected]

 

About Dr. Martens plc

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSTBBRTMTJBBBI

Related Shares:

Dr. Martens
FTSE 100 Latest
Value8,582.81
Change-76.04